All News #Library
Biotech
RevolKa Ltd. Joins Japanese AMED Biologics R&D Program
30 Jun 2025 //
BUSINESSWIRE
RevolKa secures 210M JPY Series A Extension funding
19 May 2025 //
BUSINESSWIRE
RevolKa Closes $1.7M Series A Extension For Drug Discovery Programs
29 Aug 2024 //
BUSINESSWIRE

Market Place
Sourcing Support